Case number 2023-1164
AstraZeneca AB v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 12, 2023 | 0 | ASTRAZENECA AB v. MYLAN PHARMACEUTICALS INC. [ORDER] [nonprecedential] (0) |
| Mar 7, 2023 | 65 | ORDER filed. Granting motion to remand [64] filed by Appellants AstraZeneca AB, AstraZeneca Pharmaceuticals LP and Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.; issuing mandate. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [908426] [MVH] [Entered: 03/07/2023 04:44 PM] (2) |
| Mar 6, 2023 | 63 | Status report for Appellants AstraZeneca AB, AstraZeneca Pharmaceuticals LP and Appellees Kindeva Drug Delivery L.P. and Mylan Pharmaceuticals Inc.. Service: 03/06/2023 by email. [907926] [23-1164] [Shannon Bloodworth] [Entered: 03/06/2023 01:07 PM] (6) |
| Mar 6, 2023 | 64 | MOTION of Appellants AstraZeneca AB, AstraZeneca Pharmaceuticals LP and Appellees Kindeva Drug Delivery L.P. and Mylan Pharmaceuticals Inc. remand for the district court to take action consistent with indicative ruling. Service: 03/06/2023 by email. [907927] [23-1164] [Shannon Bloodworth] [Entered: 03/06/2023 01:17 PM] (12) |
| Feb 27, 2023 | 62 | ORDER filed granting joint motion to stay appeal in 23-1164 [61] and 23-1267 [906408-2]. Please see order for full and complete details. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [906521] [23-1164, 23-1267] [MVH] [Entered: 02/27/2023 02:51 PM] (2) |
| Feb 27, 2023 | 61 | MOTION of Appellees Mylan Pharmaceuticals Inc., Kindeva Drug Delivery L.P. and Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP to stay appeal. Service: 02/27/2023 by email. [906406] [23-1164] [Shannon Bloodworth] [Entered: 02/27/2023 11:15 AM] (12) |
| Feb 6, 2023 | 60 | Response to notice of oral argument from Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 02/06/2023 by clerk. [902151] [23-1164] [Andrew Dufresne] [Entered: 02/06/2023 02:18 PM] (1) |
| Feb 2, 2023 | 59 | 6 paper copies of Doc. No. [57] received from Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. [901691] [VDW] [Entered: 02/03/2023 09:10 AM] (0) |
| Feb 1, 2023 | 58 | Response to notice of oral argument from Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 02/01/2023 by email. [901416] [23-1164] [David Berl] [Entered: 02/01/2023 05:47 PM] (1) |
| Jan 25, 2023 | 57 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL APPENDIX FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/25/2023 by email. Paper copies of this brief must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [899699]--[Edited 01/31/2023 by ALK - compliance review complete] [David Berl] [Entered: 01/25/2023 05:10 PM] (0) |
| Jan 25, 2023 | 56 | NOTICE OF NON-COMPLIANCE: The submission of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP, Confidential Appendix [55], is not in compliance with the rules of this court (see attached). Compliant document due on 02/01/2023. Service as of this date by the Clerk of Court. [899628] [ALK] [Entered: 01/25/2023 03:51 PM] (1) |
| Jan 24, 2023 | 55 | CORRECTED CONFIDENTIAL APPENDIX FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/24/2023 by email. [899309] [23-1164] This document is non-compliant. See Doc No. [56]. [David Berl] [Entered: 01/24/2023 06:39 PM] (0) |
| Jan 24, 2023 | 54 | MODIFIED ENTRY: CORRECTED APPENDIX FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/24/2023 by email. [899307] --[Edited 01/25/2023 by ALK - compliance review complete] [David Berl] [Entered: 01/24/2023 06:36 PM] (898) |
| Jan 24, 2023 | 53 | Notice of Correction to Doc No. [46] for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/24/2023 by email. [899306] [23-1164] [David Berl] [Entered: 01/24/2023 06:34 PM] (3) |
| Jan 23, 2023 | 52 | NOTICE OF ORAL ARGUMENT. Panel: 2303L. Case scheduled March 8, 2023. Response to Notice of Oral Argument due: 02/06/2023. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [898811] [MJL] [Entered: 01/23/2023 04:21 PM] (2) |
| Jan 20, 2023 | 50 | NOTICE OF NON-COMPLIANCE: The submission of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP, Confidential Appendix [47], is not in compliance with the rules of this court (see attached). Compliant document due on 01/27/2023. Service as of this date by the Clerk of Court. [898426] [ALK] [Entered: 01/20/2023 03:19 PM] (1) |
| Jan 19, 2023 | 49 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/19/2023 by email. [898218] [23-1164] [David Berl] [Entered: 01/19/2023 07:49 PM] (2) |
| Jan 19, 2023 | 48 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 01/19/2023 by email. [898216] [23-1164] [Nathan Kelley] [Entered: 01/19/2023 07:22 PM] (2) |
| Jan 19, 2023 | 47 | CORRECTED CONFIDENTIAL APPENDIX FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/19/2023 by email. [898213] [23-1164] This document is non-compliant. See Doc No. [50]. [David Berl] [Entered: 01/19/2023 06:57 PM] (0) |
| Jan 19, 2023 | 46 | MODIFIED ENTRY: CORRECTED APPENDIX FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/19/2023 by email. [898212] --[Edited 01/20/2023 by ALK - compliance review complete] [David Berl] [Entered: 01/19/2023 06:48 PM] (827) |
| Jan 19, 2023 | 45 | Notice of Correction to Doc No. [44] for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/19/2023 by email. [898210] [23-1164] [David Berl] [Entered: 01/19/2023 06:39 PM] (3) |
| Jan 18, 2023 | 44 | APPENDIX FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/18/2023 by email. [897792] [23-1164]--[Edited 01/18/2023 by JCP to lock document filed with confidential information in error] [David Berl] [Entered: 01/18/2023 04:29 PM] (0) |
| Jan 17, 2023 | 51 | 6 paper copies of Doc. No. [41] received from Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. [898531] [VDW] [Entered: 01/23/2023 09:15 AM] (0) |
| Jan 13, 2023 | 43 | ORDER filed denying Mylan's Rule 8 motion [891884-2]. The temporary stay entered on December 21, 2022, is lifted.; granting motion to expedite [891888-2] to the following extent: (a) in Appeal No. 2023-1267, AstraZeneca's response brief is due no later than February 9, 2023; Mylan's reply brief is due no later than February 16, 2023; the joint appendix is due no later than February 17, 2023; and (b) Appeal Nos. 2023-1164 and 2023-1267 shall be considered companion cases and set for argument before the same panel on March 8, 2023, at 10:00 AM, superseding the notice of oral argument for Appeal No. 2023-1164 issued on December 9, 2022. (Per Curiam). Service as of this date by the Clerk of Court. [896981] [23-1267, 23-1164] [LMS] [Entered: 01/13/2023 03:34 PM] (3) |
| Jan 12, 2023 | 41 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/12/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. Paper copies of this brief must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [896617] --[Edited 01/13/2023 by ALK - compliance review complete] [David Berl] [Entered: 01/12/2023 01:27 PM] (44) |
| Jan 10, 2023 | 42 | 6 paper copies of Doc. No. [37] received from Appellees Kindeva Drug Delivery L.P. and Mylan Pharmaceuticals Inc.. [896653] [VDW] [Entered: 01/12/2023 03:03 PM] (0) |
| Jan 9, 2023 | 40 | 6 paper copies of Doc. No. [15] received from Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. [896415] [VDW] [Entered: 01/11/2023 04:16 PM] (0) |
| Jan 5, 2023 | 39 | Corrected Response to notice of oral argument from Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/05/2023 by email. [894847] [23-1164] [David Berl] [Entered: 01/05/2023 12:04 PM] (1) |
| Jan 5, 2023 | 38 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Appellants' response to notice of oral argument (RNOA) [34] indicates that counsel intends to argue for a total of 20 minutes. Main argument time and rebuttal time together must not exceed 15 minutes. CORRECTION: No later than 01/12/2023, please file a corrected RNOA that identifies a time division that does not exceed 15 total minutes. [894802] [MJL] [Entered: 01/05/2023 11:07 AM] (0) |
| Jan 3, 2023 | 37 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Kindeva Drug Delivery L.P. and Mylan Pharmaceuticals Inc. Service: 01/03/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. Paper copies of this brief must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [894324] --[Edited 01/05/2023 by ALK - compliance review complete] [Nathan Kelley] [Entered: 01/03/2023 08:01 PM] (77) |
| Jan 3, 2023 | 36 | Amended Certificate of Interest for Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 01/03/2023 by email. [894221] [23-1164] [Nathan Kelley] [Entered: 01/03/2023 02:39 PM] (3) |
| Dec 30, 2022 | 35 | Response to notice of oral argument from Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 12/30/2022 by clerk. [894000] [23-1164] [Andrew Dufresne] [Entered: 12/30/2022 06:01 PM] (1) |
| Dec 30, 2022 | 34 | Response to notice of oral argument from Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 12/30/2022 by email. [893986] [23-1164] [David Berl] [Entered: 12/30/2022 04:37 PM] (1) |
| Dec 23, 2022 | 33 | Entry of Appearance for Matthew Greinert as counsel for Appellee Mylan Pharmaceuticals Inc. Service: 12/23/2022 by clerk. [892829] [MVH] [Entered: 12/23/2022 04:51 PM] (1) |
| Dec 23, 2022 | 32 | Entry of Appearance for Dan L. Bagatell as counsel for Appellees Kindeva Drug Delivery L.P. and Mylan Pharmaceuticals Inc. Service: 12/23/2022 by. [892827] [MVH] [Entered: 12/23/2022 04:50 PM] (1) |
| Dec 23, 2022 | 31 | Entry of Appearance for Kevin Hoagland-Hanson as counsel for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 12/23/2022 by clerk. [892825] [MVH] [Entered: 12/23/2022 04:49 PM] (1) |
| Dec 23, 2022 | 30 | ORDER filed granting motions for leave to appear as counsel filed by Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.l [29] and filed by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP [28]. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [892823] [MVH] [Entered: 12/23/2022 04:48 PM] (2) |
| Dec 22, 2022 | 29 | MOTION of Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. for leave to file entry of appearance for Dan L. Bagatell; Matthew Greinert. Service: 12/22/2022 by email. [892577] [23-1164] [Nathan Kelley] [Entered: 12/22/2022 06:16 PM] (8) |
| Dec 22, 2022 | 28 | MOTION of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP for leave to file entry of appearance for Kevin Hoagland-Hanson. Service: 12/22/2022 by email. [892570] [23-1164] [David Berl] [Entered: 12/22/2022 05:52 PM] (9) |
| Dec 22, 2022 | 27 | NOTICE OF NON-COMPLIANCE: The submission of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP, Entry of Appearance [26], is not in compliance with the rules of this court (see attached). Compliant document due on 12/30/2022. Service as of this date by the Clerk of Court. [892500] [CMH] [Entered: 12/22/2022 02:17 PM] (1) |
| Dec 13, 2022 | 26 | Entry of Appearance for Kevin Hoagland-Hanson as counsel for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 12/13/2022 by email. [890467] [23-1164] This document is non-compliant. See Doc No. [27]. [David Berl] [Entered: 12/13/2022 04:20 PM] (1) |
| Dec 13, 2022 | 25 | NOTICE OF NON-COMPLIANCE: The submissions of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP, Opening Brief and Confidential Opening Brief, [15] and [16], are not in compliance with the rules of this court (see attached). Compliant documents due on 12/20/2022. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [890410] [ALK] [Entered: 12/13/2022 02:36 PM] (1) |
| Dec 9, 2022 | 24 | NOTICE OF ORAL ARGUMENT. Panel: 2302B. Case scheduled February 10, 2023. Response to Notice of Oral Argument due: 12/30/2022. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [889705] [MJL] [Entered: 12/09/2022 03:04 PM] (2) |
| Dec 7, 2022 | 23 | ORDER filed denying [10] [13] the motion to expedite filed by AstraZeneca AB and AstraZeneca Pharmaceuticals LP. (Per Curiam). Service as of this date by the Clerk of Court. [889049] [LMS] [Entered: 12/07/2022 11:51 AM] (2) |
| Dec 6, 2022 | 22 | Entry of Appearance for Andrew T. Dufresne as counsel for Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 12/06/2022 by clerk. [888730] [23-1164] [Andrew Dufresne] [Entered: 12/06/2022 02:38 PM] (1) |
| Dec 2, 2022 | 21 | REPLY of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP to response [19]. Service: 12/02/2022 by email. [887968] [23-1164] [David Berl] [Entered: 12/02/2022 03:15 PM] (10) |
| Dec 2, 2022 | 20 | Docketing Statement for the Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 12/02/2022 by email. [887967] [23-1164] [Nathan Kelley] [Entered: 12/02/2022 03:13 PM] (2) |
| Nov 29, 2022 | 19 | RESPONSE of Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. to Doc No. [13], [13]. Service: 11/29/2022 by email. [887072] [23-1164] [Nathan Kelley] [Entered: 11/29/2022 08:51 PM] (16) |
| Nov 28, 2022 | 18 | Certificate of Interest for Appellees Kindeva Drug Delivery L.P. and Mylan Pharmaceuticals Inc.. Service: 11/28/2022 by email. [886811] [23-1164] [Nathan Kelley] [Entered: 11/28/2022 06:20 PM] (3) |
| Nov 28, 2022 | 17 | Corrected Certificate of Service filed by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP to Doc No. [15]. Service: 11/28/2022 by email. [886810] [23-1164] [David Berl] [Entered: 11/28/2022 06:12 PM] (1) |
| Nov 23, 2022 | 16 | OPENING BRIEF FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/23/2022 by email. (PENDING COMPLIANCE REVIEW) [886509] [23-1164] [David Berl] [Entered: 11/23/2022 08:17 PM] (172) |
| Nov 23, 2022 | 15 | CONFIDENTIAL OPENING BRIEF FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/23/2022 by email. (PENDING COMPLIANCE REVIEW) [886508] [23-1164] [David Berl] [Entered: 11/23/2022 08:14 PM] (0) |
| Nov 22, 2022 | 14 | ORDER Any opposition to the motion [13] is due no later than seven days from the date of filing of this order. Any reply is due no later than three days thereafter. AstraZeneca's opening brief is due no later than 11/23/2022. Service as of this date by the Clerk of Court. [886159] [NL] [Entered: 11/22/2022 02:45 PM] (2) |
| Nov 21, 2022 | 13 | MOTION of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP to expedite briefing schedule, to expedite hearing. Service: 11/21/2022 by email. [885477] [23-1164] [David Berl] [Entered: 11/21/2022 01:28 PM] (13) |
| Nov 21, 2022 | 12 | Notice of Correction to Doc No. [10], [10] for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/21/2022 by email. [885475] [23-1164] [David Berl] [Entered: 11/21/2022 01:26 PM] (3) |
| Nov 21, 2022 | 11 | Docketing Statement for the Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/21/2022 by email. [885315] [23-1164] [David Berl] [Entered: 11/21/2022 10:49 AM] (2) |
| Nov 21, 2022 | 10 | MOTION of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP to expedite briefing schedule, to expedite hearing. Service: 11/21/2022 by email. [885312] [23-1164] [David Berl] [Entered: 11/21/2022 10:47 AM] (9) |
| Nov 21, 2022 | 9 | Amended Certificate of Interest for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/21/2022 by email. [885300] [23-1164] [David Berl] [Entered: 11/21/2022 10:33 AM] (4) |
| Nov 21, 2022 | 8 | Amended Entry of appearance for David I. Berl; David M. Krinsky; Anthony Sheh; Jessica P. Ryen; Arthur J. Argall III; Christopher N. Sipes; Tarek Austin; Gary M. Rubman; Douglas A. Behrens; Matthew Kudzin as counsel for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/21/2022 by email. [885297] [23-1164] [David Berl] [Entered: 11/21/2022 10:30 AM] (3) |
| Nov 21, 2022 | 7 | NOTICE OF NON-COMPLIANCE: The submission of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP, Motion to Expedite [3], is not in compliance with the rules of this court (see attached). Compliant document due on 11/30/2022. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [885260] [ALK] [Entered: 11/21/2022 09:35 AM] (1) |
| Nov 21, 2022 | 6 | NOTICE OF NON-COMPLIANCE: The submission of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP, Entry of Appearance [2], is not in compliance with the rules of this court (see attached). Compliant document due on 11/30/2022. Service as of this date by the Clerk of Court. [885250] [ALK] [Entered: 11/21/2022 09:16 AM] (1) |
| Nov 21, 2022 | 5 | Entry of appearance for Shannon M. Bloodworth; David L. Anstaett; Nathan K. Kelley; Emily J. Greb; Brandon M. Lewis as counsel for Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 11/21/2022 by email. [885239] [23-1164] [Nathan Kelley] [Entered: 11/21/2022 08:37 AM] (2) |
| Nov 18, 2022 | 4 | Certificate of Interest for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/18/2022 by email. [885217] [23-1164] [David Berl] [Entered: 11/18/2022 05:49 PM] (4) |
| Nov 18, 2022 | 3 | MOTION of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP to expedite briefing schedule, to expedite hearing. Service: 11/18/2022 by email. [885150] [23-1164] This document is non-compliant. See Doc No. [7]. [David Berl] [Entered: 11/18/2022 04:04 PM] (9) |
| Nov 18, 2022 | 2 | Entry of appearance for David I. Berl; David M. Krinsky; Anthony Sheh; Jessica P. Ryen; Kevin D. Hoagland-Hanson; Arthur J. Argall III; Christopher N. Sipes; Gary M. Rubman; Douglas A. Behrens; Matthew Kudzin; Tarek Austin as counsel for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/18/2022 by email. [885139] [23-1164] This document is non-compliant. See Doc No. [6]. [David Berl] [Entered: 11/18/2022 03:54 PM] (3) |
| Nov 18, 2022 | 1 | Appeal docketed. Received: 11/11/2022. [885032]Entry of Appearance is due on 12/02/2022. Certificate of Interest is due on 12/02/2022. Docketing Statement is due on 12/02/2022. Appellants' brief is due on 01/17/2023. [ALK] [Entered: 11/18/2022 01:56 PM] (168) |
